DealsAstraZeneca to buy PE-backed Amolyt Pharma for $1.05bnAmolyt Pharma is a global clinical-stage biopharmaceutical company.ByIrien Joseph14 March 2024•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcare